Kenneth R. Shroyer

Dr. Kenneth R. Shroyer is a SUNY Distinguished Professor and Chair of the Department of Pathology at Stony Brook Medicine, with a career spanning over three decades in anatomic and clinical pathology, cytopathology, and gynecologic oncology. He pioneered foundational methods in in situ hybridization and tyramide signal amplification, and currently leads research on nuclear keratin 17 as a biomarker in carcinomas.

• Prior Affiliation: University of Colorado Health Sciences Center (1991-2007)
• Academic Training: PhD in Experimental Pathology (University of Colorado), MD (University of Colorado School of Medicine)
• Leadership: President of Stony Brook Pathologists, Director of Cytopathology & Surgical Pathology (1993-2007)

Research Interests focus on molecular pathology of cancers, particularly keratin 17's role in pancreatic, gynecologic, and lung carcinomas. His work bridges immunohistochemistry, nano-biotechnology, and digital pathology for improved diagnostics.

Publication Trends show sustained contributions to pancreatic cancer (2019-2024), lung cancer (2024), and foundational work in cell immortality markers (2002). Recent studies emphasize immune topography analysis and molecular diagnostics.

• Scientific Awards
  • 2025 SUNY Distinguished Professor
  • 2023 National Academy of Inventors Induction
  • 2018 Pancreatic Cancer Action Network Award
  • Numerous Top Doctor and Best Paper Recognitions

Labs & Collaborations: Dr. Shroyer's lab collaborates with biomedical engineers on nano-particle antibody labeling for in vivo imaging and high-sensitivity diagnostics. His team contributes to the Molecular and Cellular Biology Program and Molecular Genetics and Microbiology Program at Stony Brook.